Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Rating for Quality Systems (QSII) Falls From a Hold to Sell

By Portfolio Grader
Portfolio Grader currently ranks Quality Systems Inc (NASDAQ:QSII) a Sell. The methodology for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Earnings Growth Make Evolent Health (EVH) a Sell

By Portfolio Grader
With a $0.9 billion market value, Evolent Health Inc (NYSE:EVH) ranks in the top half of its industry group, Health Care Technology, and in the upper half of its sector group, Health Care, in market value. From the prospective of investment attractiveness, the stock's Portfolio Grader ranking currently places it 22 among the 24 companies in this industry group, a spot that is well below-average; squarely in the bottom quartile of the sector with a ranking of 601 among the 785 companies in the sector, and number 3,713 in the nearly 5,000 company Portfolio Grader universe.

NVIDIA Corporation (NVDA) Earnings Destroy Expectations

By Karl Utermohlen, InvestorPlace Writer
NVIDIA Corporation (NVDA) unveiled its quarterly earnings results after hours, crushing Wall Street's expectations in profit and revenue.

Shares of HMS Holdings (HMSY) Reduced to Sell

By Portfolio Grader
Currently, HMS Holdings Corp (NASDAQ:HMSY) has a Sell using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing approach. HMSY has been downgraded from a Hold to a Sell in the last week.

Compelling Earnings Growth Analytics Raise Ranking of Omnicell (OMCL) to Strong Buy

By Portfolio Grader
Omnicell Inc (NASDAQ:OMCL) ranks in the top half of its industry group, Health Care Technology, and in the top 25% of its sector group, Health Care, with a market value of $1.9 billion. From an investment attractiveness viewpoint, OMCL is ranked in the top decile of the sector with a ranking of 14 among the 785 companies in the sector; the stock's current Portfolio Grader score places it 1 among the 24 companies in this industry group, positioning it among the leaders and number 113 in the 5000 company Portfolio Grader company universe.

Inovalon Holding (INOV) Earnings Momentum Penalize Rating

By Portfolio Grader
With a $2.3 billion market value, Inovalon Holding Inc (NASDAQ:INOV) ranks in the upper half of its industry group, Health Care Technology, and in the top 25% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, The current Portfolio Grader ranking for INOV puts it 14 among the 24 companies in this industry group, giving it a below-average spot; in the third quartile of the sector with a ranking of 397 among the 785 companies in the sector, and number 2,586 in the nearly 5,000 company Portfolio Grader universe.

Quant Score Analytics Keep Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to Hold

By Portfolio Grader
Allscripts Healthcare Solutions (NASDAQ:MDRX) is ranked as a Hold using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The shares have been upgraded from a Sell to a Hold in the last week.

Feeble Earnings Momentum Restrict Cotiviti Holdings (COTV) Rating

By Portfolio Grader
Portfolio Grader currently ranks Cotiviti Holdings Inc (NYSE:COTV) a Hold. Using Louis Navellier's investing methodology, this analytical tool assesses stocks by employing proprietary fundamental and quantitative metrics. This represents no change from the previous week and is the same ranking COTV has had from Portfolio Grader for 2 months.

Vapid Sales Growth Limit INC Research Holdings (INCR) Rating

By Portfolio Grader
Currently, INC Research Holdings Inc (NASDAQ:INCR) has a Hold using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. INCR has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.

Medidata Solutions (MDSO) Sees Rating Drop….. Eroding Quant Score

By Portfolio Grader
Portfolio Grader currently ranks Medidata Solutions (NASDAQ:MDSO) a Hold. The methodology for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

VWR Corp (VWR) a Hold on Uninspiring Earnings Momentum

By Portfolio Grader
VWR Corp (NASDAQ:VWR) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top quarter of its sector group, Health Care, with a market value of $4.4 billion. From an investment attractiveness prospective, VWR is ranked in the top half of the sector with a ranking of 266 among the 785 companies in the sector; The current Portfolio Grader ranking for VWR puts it 19 among the 33 companies in this industry group, which is a below-average position and number 1,720 in the 5000 company Portfolio Grader company universe.

Robust Earnings Momentum Metrics Drive Upgrade of Bio-Techne (TECH) to Buy

By Portfolio Grader
Portfolio Grader currently ranks Bio-Techne Corp (NASDAQ:TECH) a Buy. Using Louis Navellier's investing approach, this analytical tool evaluates stocks by employing proprietary fundamental and quantitative analytical tools. The shares have been upgraded from a Hold to a Buy in the last week.

Why the Big Rally In Roku Inc Stock Is Overdone

By Luke Lango, InvestorPlace Senior Investment Analyst
ROKU stock is up big after blowout earnings, but one good report for Roku doesn't eliminate mounting competition concerns.

6 Stocks Dragging the Stock Market Down

By Anthony Mirhaydari, InvestorPlace Market Strategist
Stocks suffer their worst pullback in months on Thursday, with the Dow giving back more than 200 points tax cut legislation concerns.

Rating on athenahealth (ATHN) Raised to Buy From a Hold

By Portfolio Grader
Portfolio Grader currently ranks athenahealth Inc (NASDAQ:ATHN) a Buy. The methods for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Excellent Earnings Visibility Metrics Drive Upgrade of PRA Health Sciences (PRAH) to Strong Buy

By Portfolio Grader
PRA Health Sciences Inc (NASDAQ:PRAH) is ranked as a Strong Buy using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Oprah’s Loss Is Weight Watchers International, Inc. Stock’s Gain

By Luke Lango, InvestorPlace Senior Investment Analyst
WTW stock has increased by more than 7 times over the past 2 years, but the Weight Watchers International, Inc. rally isn't done yet.

Bruker (BRKR) a Buy on Strong Quant Score

By Portfolio Grader
Bruker Corp (NASDAQ:BRKR) is classified as a component of the 33 company Life Sciences Tools & Services GICS industry group, which is part of the 785 company GICS Health Care sector. BRKR's market value is $5.3 billion which falls in the upper half of its industry group. The ranking for BRKR by Portfolio Grader places it 9 among the 33 companies in this industry group, placing it in the top half; in the top quartile of the sector with a ranking of 98 among the 785 companies in the sector, and number 641 in the nearly 5,000 company Portfolio Grader universe.

Commanding Earnings Momentum Metrics Raise Ranking of Charles River Labs (CRL) to Strong Buy

By Portfolio Grader
Charles River Labs (NYSE:CRL) is ranked as a Strong Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. CRL has been upgraded from a Buy to a Strong Buy in the last week.
Load More Articles